Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tear film proteins represent a diverse proteome of over 1,500 proteins essential for maintaining ocular surface health and visual clarity (Zhou et al., 2012). Major components include antimicrobial proteins like lysozyme and lactoferrin, which provide the first line of defense against pathogens, and lipocalin-1, which stabilizes the tear film (Ohashi et al., 2003). Mucins, such as MUC5AC, are critical glycoproteins that hydrate the ocular surface and reduce friction during blinking (Mantelli & Argüeso, 2008). In diseases like dry eye and Sjögren's syndrome, the balance of these proteins is disrupted, often characterized by an increase in inflammatory markers like Matrix Metalloproteinase-9 (MMP-9) and a decrease in protective proteins (Sambursky et al., 2013). Pharmacological interventions like cyclosporine and lifitegrast aim to reduce inflammation to restore normal protein secretion, while newer agents like varenicline stimulate the lacrimal functional unit to increase endogenous tear production (FDA, 2021). Understanding the tear proteome is vital for developing targeted therapies and diagnostic biomarkers for ocular surface disorders.
Modulation of inflammatory pathways to restore natural protein secretion, supplementation of tear film components, and stimulation of the lacrimal functional unit to increase endogenous protein production.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tear film proteins.